Matthew Coates

ORCID: 0000-0001-8976-5015 · 5 papers in corpus · active 2020-2023

Study types

  • article 1
2023
Crohn's & colitis 360 ·doi:10.1093/crocol/otad055

Abdominal pain is one of the most common and impactful symptoms associated with inflammatory bowel disease (IBD), including both Crohn's disease and ulcerative colitis. A great deal of research has been undertaken over the past several year…

2023
Inflammatory intestinal diseases ·doi:10.1159/000534413

IntroductionHypoalgesic or silent inflammatory bowel disease (IBD) is a poorly understood condition that has been associated with poor clinical outcomes. There is evidence that lifestyle factors, including diet, exercise, and substance use …

2023
Digestive diseases and sciences ·doi:10.1007/s10620-023-08075-0

BackgroundLifestyle factors, including diet, exercise, substance use, and sexual activity, have been shown to influence risk of inflammation and complications in inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerativ…

2021
International journal of colorectal disease ·doi:10.1007/s00384-020-03727-3

ObjectivesInflammation is an important driver of abdominal pain in inflammatory bowel disease (IBD). However, some patients in remission still experience pain. We aimed to identify risk factors associated with abdominal pain in quiescent IB…

article 2020
·doi:10.14309/01.ajg.0000714840.05592.f8

INTRODUCTION: Antidepressant medications (AMs) are frequently used in inflammatory bowel disease (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC). Many AMs are designed to enhance serotonin (5-HT) signaling. Increased 5-HT …